About Springfield Neurology Associates
Clinical Trials at Springfield Neurology Associates
During the past decade, Springfield Neurology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Springfield Neurology Associates" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials, followed by "AstraZeneca" with 1 trials
sponsored, "Cerecin" with 1 trials sponsored, "GlaxoSmithKline" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Springfield Neurology Associates"
#1 collaborator was "Pfizer" with 2 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Springfield Neurology Associates
According to Clinical.Site data, the most researched conditions in "Springfield Neurology Associates" are
"Alzheimer's Disease" (4 trials), "Alzheimer´s Disease" (1 trials), "Headache, Tension-Type" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Springfield Neurology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Springfield Neurology Associates
Most popular intervention types in "Springfield Neurology Associates" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials) and "AC-1204" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Springfield Neurology Associates
The vast majority of trials in "Springfield Neurology Associates" are
7 trials for "All" genders.
Clinical Trials Status at Springfield Neurology Associates
Currently, there are NaN active trials in "Springfield Neurology Associates".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Springfield Neurology Associates,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Springfield Neurology Associates, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".